Are you interested in lowering your risk of developing Alzheimer’s disease and other types of dementia? We can take actions ...

With a shared purpose, we can realize the true promise of CRISPR and improve healthcare, providing hope to more patients with ...

Sales growth driven by continued strong performance from priority brands including Kisqali (+57% cc), Kesimpta (+36% cc), Pluvicto (+42% cc), Scemblix (+85% cc) and Cosentyx (+8% cc) Core operating ...

Researchers at the NIHR Leeds Biomedical Research Centre (BRC) and the University of Leeds have led an innovative new project studying how to bridge the gap between patients with PMR (Polymyalgia ...

Polymyalgia rheumatica (PMR) is the most common form of joint inflammation and affects around two per cent of people over the ...

New research could allow health care providers to identify and treat patients at risk for rheumatoid arthritis before the disease progresses.

Editor's Note: The following contains spoilers for '28 Years Later: The Bone Temple'28 Years Later: The Bone Temple is finally here, and yes, it really is as good as you've heard it is. Director Nia ...

Kyle Donahue survived glioblastoma for five years after joining a clinical trial at Brigham and Women's Hospital. The trial used CAN-3110, an engineered herpes virus, to target and kill glioblastoma ...

President Trump’s comments were a blunt distillation of his administration’s racial politics, which rest on the belief that white people have become the real victims of discrimination in America. By ...

An estimated five million people are unable to see the world around them because they suffer from an advanced form of age-related macular degeneration (AMD) called geographic atrophy. The condition ...